| Authors: |
Costa KM; National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. kaue.m.costa@gmail.com., Scholz R; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.; Max Planck School of Cognition, Leipzig, Germany., Lloyd K; Max Planck Institute for Biological Cybernetics, Tübingen, Germany., Moreno-Castilla P; National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, MD, USA., Gardner MPH; Concordia University, Montreal, Quebec, Canada., Dayan P; Max Planck Institute for Biological Cybernetics, Tübingen, Germany.; University of Tübingen, Tübingen, Germany., Schoenbaum G; National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA. geoffrey.schoenbaum@nih.gov. |